Track QSAM Biosciences's total current liabilities ($1M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
QSAM Biosciences (QSAM) currently reports a total current liabilities of $1M as of December 2023. That compares with $1.6M in the prior-year period — down 34.6% year over year. Use the charts on this page to explore QSAM Biosciences's total current liabilities history and peer comparisons.
QSAM Biosciences's total current liabilities decreased from $1.6M to $1M — a 34.6% year-over-year decrease (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
QSAM Biosciences reported $1M in total current liabilities as of December 2023. That compares with $1.6M in the prior-year period — down 34.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total current liabilities of $1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for QSAM Biosciences, and consider following QSAM for alerts when major investors trade the stock.
QSAM Biosciences is classified in the Materials sector. On total current liabilities, it currently shows $1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing QSAM with unrelated industries.